Alodo, Isaiah Gabrielle C.
HRN: 22-56-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/25/2024
05/31/2024
IVT
5mL
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes